A CONJUGATE CONSISTING OF OR COMPRISING AT LEAST A ß-GLUCAN OR A MANNAN Application WO-2023161527-A1 World Intellectual Property Organisation (WIPO) 31 Aug 2023
Method for vaccination against a self-antigen in a human patient Grant AU-2016348610-B2 Australia 31 Aug 2023
ANTI-ALPHA-SYNUCLEIN THERAPEUTIC VACCINES Application WO-2023152260-A1 World Intellectual Property Organisation (WIPO) 17 Aug 2023
IMMUNOGENIC COMPOUNDS Application WO-2022029181-A1 World Intellectual Property Organisation (WIPO) 10 Feb 2022
PEPTIDE IMMUNOGENS FROM THE C-TERMINAL END OF ALPHA-SYNUCLEIN PROTEIN AND FORMULATIONS… Application EP-3638298-A4 European Patent Office 05 May 2021
Methods, antibodies, and vaccines utilizing epitopes of alpha synuclein for treatment of… Grant US-10653759-B2 United States of America 19 May 2020
Methods, antibodies, and vaccines utilizing epitopes of alpha synuclein for treatment of… Grant US-10155030-B2 United States of America 18 Dec 2018
METHOD FOR VACCINATION AGAINST A SELF-ANTIGEN IN A HUMAN PATIENT Application WO-2017076873-A1 World Intellectual Property Organisation (WIPO) 11 May 2017
TREATMENT AND PREVENTION OF PARKINSON'S DISEASE (PD) Application WO-2015185602-A1 World Intellectual Property Organisation (WIPO) 10 Dec 2015